Previous Article | Next Article ![]()
Infection and Immunity, April 2001, p. 2230-2236, Vol. 69, No. 4
Section of Infectious Diseases, Boston
Medical Center, Boston, Massachusetts 02118,1
and Institute of Cancer Research and Molecular Biology,
Norwegian University of Science and Technology, 7489 Trondheim,
Norway2
Received 23 August 2000/Returned for modification 5 October
2000/Accepted 12 January 2001
The recent isolation of a lipopolysaccharide (LPS)-deficient mutant
of Neisseria meningitidis has allowed us to explore the roles of other gram-negative cell wall components in the host response
to infection. The experiments in this study were designed to examine
the ability of this mutant strain to activate cells. Although it was
clearly less potent than the parental strain, we found the
LPS-deficient mutant to be a capable inducer of the inflammatory
response in monocytic cells, inducing a response similar to that seen
with Staphylococcus aureus. Cellular activation by the LPS
mutant was related to expression of CD14, a high-affinity receptor for
LPS and other microbial products, as well as Toll-like receptor 2, a
member of the Toll family of receptors recently implicated in host
responses to gram-positive bacteria. In contrast to the parental
strain, the synthetic LPS antagonist E5564 did not inhibit the
LPS-deficient mutant. We conclude that even in the absence of LPS, the
gram-negative cell wall remains a potent inflammatory stimulant,
utilizing signaling pathways independent of those involved in LPS signaling.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.4.2230-2236.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Membrane-Associated Proteins of a
Lipopolysaccharide-Deficient Mutant of Neisseria
meningitidis Activate the Inflammatory Response through
Toll-Like Receptor 2
*
Corresponding author. Mailing address: Evans Biomedical
Research Center, 650 Albany St., Boston, MA 02118. Phone: (617)
414-4778. Fax: (617) 414-5280. E-mail: ringalls{at}bu.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|